2/28/25 17:57  | 2/26/25  | GKOS | Glaukos Corp | DE | Health | MdEq | Surgical & Medical Instrument | Foley Mark J | CA | D |  | M.d | 1,170 | 29.26 | 0 | 40 | 281 | 54 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/28/25 17:57  | 2/26/25  | GKOS | Glaukos Corp | DE | Health | MdEq | Surgical & Medical Instrument | Foley Mark J | CA | D |  | S.d | -2,497 | 120.72 | 0 | -21 | -28 | 54 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/8/24 16:33  | 3/6/24  | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foley Mark J | TN | DO | CEO | P | 209 | 6.98 | 0 | 30 | 3 | 1,126 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/26/24 19:01  | 2/23/24  | GKOS | Glaukos Corp | DE | Health | MdEq | Surgical & Medical Instrument | Foley Mark J | CA | D |  | M.d | 73 | 7.28 | 0 | 10 | 43 | 33 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
2/26/24 19:01  | 2/23/24  | GKOS | Glaukos Corp | DE | Health | MdEq | Surgical & Medical Instrument | Foley Mark J | CA | D |  | S.d | -423 | 92.87 | 0 | -5 | -12 | 33 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
8/4/23 17:07  | 8/3/23  | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foley Mark J | TN | DO | CEO | S | -593 | 22.57 | 0 | -26 | -3 | 951 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
7/5/23 21:11  | 7/3/23  | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foley Mark J | TN | DO | CEO | S | -655 | 24.94 | 0 | -26 | -3 | 978 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
6/13/23 20:09  | 6/9/23  | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foley Mark J | TN | DO | CEO | S | -961 | 30.72 | 0 | -31 | -3 | 1,003 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
5/16/23 20:29  | 5/15/23  | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foley Mark J | TN | DO | CEO | S | -2,434 | 34.55 | 0 | -70 | -6 | 1,034 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 
3/9/23 21:45  | 3/9/23  | RVNC | Revance Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Foley Mark J | TN | DO | CEO | S | -2,223 | 31.59 | 0 | -70 | -7 | 934 | D |  |  |  |  |  |  |  |  |  |  |  |  |  |  |